# A Study to Characterize the Pharmacokinetics of DA-8031 in Healthy Male Subjects

> **NCT01104948** · PHASE1 · COMPLETED · sponsor: **Dong-A Pharmaceutical Co., Ltd.** · enrollment: 106 (actual)

## Conditions studied

- Premature Ejaculatory Dysfunction

## Interventions

- **DRUG:** DA-8031
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01104948
- **Lead sponsor:** Dong-A Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2012-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01104948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01104948, "A Study to Characterize the Pharmacokinetics of DA-8031 in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01104948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*